N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
We spoke with Nigel today and asked about the progress the company is making and shareholders question.
N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre-clinical and clinical programs, N4 Pharma will seek to receive upfront payments, milestone payments and ultimately royalty payments once products reach the market.
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
Listen On
Also Listen
-
Zak Mir talks to Ippolito Cattaneo, Chief Executive Officer of Ajax Resources Plc
Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources, in the wake of this w -
Zak Mir talks to Segun Lawson, President & CEO of Thor Explorations
Zak Mir talks to Segun Lawson, President & CEO of Thor Explorations, in the wake -
Zak Mir talks to Howard White, Interim Chairman, Hydrogen Utopia International
Zak's Traders Cafe spoke with Howard White, interim chairman of Hydrogen Utopia -
Panther Metals (LON: PALM) Bitcoin, Tailings, and a High-Conviction Pivot
In a recent conversation with Zak Mir from Zak’s Traders Café, Panther Metals CE